Table 1.
Reference | Study Type | PEDro | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | TOTAL | ||
Genc et al., 2015 [18] | Randomized controlled | + | + | + | + | - | - | - | + | + | + | + | 7 |
Alp et al., 2014 [30] | Non-randomized controlled | + | - | - | + | + | - | - | + | + | + | + | 6 |
de Abreu et al., 2012 [31] | Observational cross-sectional | + | - | - | + | - | - | - | + | + | + | + | 5 |
Garrido et al., 2017 [32] | Observation longitudinal | + | - | - | + | - | - | - | + | + | + | + | 5 |
Geis et al., 2012 [33] | Non-randomized controlled | + | - | - | + | - | - | - | + | + | + | + | 5 |
Pernambuco et al., 2018 [34] | Clinical randomized controlled | + | + | + | + | - | - | + | + | + | + | + | 8 |
Riva et al., 2010 [35] | Non-randomized controlled | + | - | - | + | - | - | - | + | + | + | + | 5 |
de Oliveira et al., 2018 [36] | Non-randomized controlled | + | - | - | + | - | - | - | + | + | + | + | 5 |
Schertzinger et al., 2018 [37] | Longitudinal | + | - | - | - | - | - | - | - | + | + | + | 3 |
Stehlik et al., 2018 [38] | Case-control | + | - | - | + | - | - | - | + | + | + | + | 5 |
Tanwar et al., 2018 [39] | Non-randomized controlled | + | - | - | - | - | - | - | + | - | + | + | 3 |
Torgrimson-Ojerio et al., 2014 [40] | Pilot | + | - | - | - | - | + | - | + | + | + | + | 5 |
S: selection criteria; 2: random allocation; 3: concealed allocation; 4: similarity at baseline; 5: subject blinding; 6: therapist blinding; 7: assessor blinding; 8: >85% measures for initial participants; 9: intention to treat; 10: between-group statistical comparisons; 11: point and variability measures. None of the selected articles had a conflict of interest.